digestive diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Male or female aged 18 years or above; 2) Patients who have symptoms or diseases related to the digestive system and whose condition requires hospitalisation for further diagnosis; 3) Patients who are able to read, understand and sign the informed consent form; 4) The investigator believes that the subject understands the clinical trial procedures, is willing and able to complete all trial procedures and follow-up visits, and will cooperate with the trial procedures.
Exclusion criteria
Exclusion criteria: 1) Patients who have participated in other clinical trials and are within the follow-up period of the other clinical trials. 2) High-risk diseases or other special conditions that, in the opinion of the investigator, make the subject unsuitable for participation in a clinical trial; and 3) Other uncooperative patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of disease diagnosis;Diagnosis and treatment quality control indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time required for diagnosis;Accuracy of disease feature extraction;Diagnostic consistency;Sensibility;Mortality rate;Specificity;Positive predictive value;Negative predictive value;diagnostic relevance;Incidence of adverse events; | — |
Countries
China
Contacts
Renmin Hospital of Wuhan University